Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)
Department of Health and Human Services ▸ National Institutes of Health
Description
This NIH opportunity supports investigator-initiated research to advance regenerative medicine without running a clinical trial. It uses the U01 cooperative agreement mechanism, meaning projects are milestone-driven and involve substantial program collaboration with NIH staff.
What it supports
- Preclinical and early translational studies that move regenerative concepts toward clinical readiness
- Development and testing of cell- and gene-based approaches, biomateria…
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)
Source
Grant ID
RFA-AR-25-013
Funding Source
Department of Health and Human Services ▸ National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- For profit organizations other than small businesses
- Small businesses
- Independent school districts
- County governments
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Private institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Public and State controlled institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Special district governments
- City or township governments
- Native American tribal governments (Federally recognized)
- State governments
Additional Eligibility Information
Other Eligible Applicants include the following:
Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy S…
Awards & Funding
Total Funding
$400,000
Funding Amount
Discretionary
Links
Documents
Similar opportunities
- Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)
- Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)
- Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)
- Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed)
- Small Grant Program for ORIP-Supported Special Emphasis Research Career Award (SERCA) K01 Recipients